AI Accelerating Drug Development: A Revolution from Lab to Clinic, or Reality's Bottleneck?
While AI promises to compress traditional drug development from 10-15 years to potentially just a few years, with companies like Insilico Medicine achieving clinical trials in 18 months, skeptics point to persistent clinical trial challenges and regulatory barriers that question whether this represents true revolution or mere hype.